» Articles » PMID: 17916865

Once Weekly Thyroxine Treatment As a Strategy to Treat Non-compliance

Overview
Journal Postgrad Med J
Specialty General Medicine
Date 2007 Oct 6
PMID 17916865
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hypothyroidism is a common disorder, which is mainly treated in primary rather than secondary care. Once daily thyroxine replacement restores euthyroidism in most patients; some patients, however, remain hypothyroid despite adequate thyroxine replacement. Non-compliance is the most common cause of lack of response to thyroxine treatment. We describe two cases of primary hypothyroidism in which daily thyroxine treatment did not restore biochemical euthyroidism but once weekly thyroxine treatment was successful. In addition we review the evidence and discuss the differential diagnosis of lack of response to thyroxine treatment. Once weekly thyroxine treatment can be a safe, well-tolerated, and effective therapy for patients with non-compliance.

Citing Articles

A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal.

Ducharme M, Scarsi C, Bettazzi E, Mautone G, Lewis Y, Celi F Thyroid. 2022; 32(8):897-904.

PMID: 35469428 PMC: 9419984. DOI: 10.1089/thy.2021.0604.


Weekly Versus Daily Levothyroxine Tablet Replacement in Adults with Hypothyroidism: A Meta-Analysis.

Chiu H, Larrazabal Jr R, Uy A, Jimeno C J ASEAN Fed Endocr Soc. 2021; 36(2):156-160.

PMID: 34966199 PMC: 8666497. DOI: 10.15605/jafes.036.02.07.


Effect of once weekly oral levothyroxine therapy.

Toro-Diez A, Sola-Sanchez E, Mangual-Garcia M Endocrinol Diabetes Metab Case Rep. 2021; 2021.

PMID: 34196276 PMC: 8284960. DOI: 10.1530/EDM-21-0045.


Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism - A review and a case report.

Topf A, Pleininger T, Motloch L, Mirna M, Kopp K, Lichtenauer M Arch Endocrinol Metab. 2021; 65(5):664-668.

PMID: 33844895 PMC: 10528578. DOI: 10.20945/2359-3997000000349.


REFRACTORY HYPOTHYROIDISM TO LEVOTHYROXINE TREATMENT: FIVE CASES OF PSEUDOMALABSORPTION.

Elbasan O, Yavuz D Acta Endocrinol (Buchar). 2020; 16(3):339-345.

PMID: 33363657 PMC: 7748222. DOI: 10.4183/aeb.2020.339.


References
1.
Grebe S, Cooke R, FORD H, Fagerstrom J, Cordwell D, Lever N . Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab. 1997; 82(3):870-5. DOI: 10.1210/jcem.82.3.3830. View

2.
Ain K, Refetoff S, Fein H, Weintraub B . Pseudomalabsorption of levothyroxine. JAMA. 1991; 266(15):2118-20. View

3.
Keck F, Loos U . Peripheral autoregulation of thyromimetic activity in man. Horm Metab Res. 1988; 20(2):110-4. DOI: 10.1055/s-2007-1010765. View

4.
Boelaert K, Franklyn J . Thyroid hormone in health and disease. J Endocrinol. 2005; 187(1):1-15. DOI: 10.1677/joe.1.06131. View

5.
Evans T . Thyroid disease. Prim Care. 2004; 30(4):625-40. DOI: 10.1016/s0095-4543(03)00087-3. View